Connor, Clark & Lunn Investment Management (CC&L)’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
|
|||||
|
2025
Q1 | $9.53M | Buy |
|
|||||
|
2024
Q4 | $13M | Buy |
|
|||||
|
2024
Q3 | $6.66M | Buy |
|
|||||
|
2024
Q2 | $6.28M | Buy |
|
|||||
|
2024
Q1 | $4.91M | Sell |
|
|||||
|
2023
Q4 | $6.12M | Buy |
|
|||||
|
2023
Q3 | $6.6M | Buy |
|
|||||
|
2023
Q2 | $2.87M | Buy |
|
|||||
|
2023
Q1 | $556K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $886K | Buy |
|